Animal models of inflammatory bowel disease

Journal of Gastroenterology

Volumn 37, Issue 6, 2002, Pages 409-417

  Hibi, Toshifumi ^a   Ogata, Haruhiko ^a   Sakuraba, Atsushi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal models; Croh's disease; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CARRAGEENAN; DEXTRAN SULFATE; HLA B27 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7; INTESTINAL TREFOIL FACTOR; OXAZOLONE; PEPTIDOGLYCAN POLYSACCHARIDE; STAT3 PROTEIN; STAT4 PROTEIN; T LYMPHOCYTE RECEPTOR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR; GROWTH PROMOTOR; LYMPHOCYTE ANTIGEN RECEPTOR; MUCIN; MUSCLE PROTEIN; NEUROPEPTIDE; PEPTIDE; TFF3 PROTEIN, RAT; TREFOIL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ADOPTIVE TRANSFER; ANIMAL MODEL; ANIMAL TISSUE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE FUNCTION; ENTERITIS; EXPERIMENTAL MODEL; GENETIC ENGINEERING; IMMUNOLOGICAL TOLERANCE; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUCOSAL IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; TRANSGENIC MOUSE; ULCERATIVE COLITIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; GENETICS; TRANSGENIC ANIMAL;

ADOPTIVE TRANSFER; ANIMAL; ANIMALS, GENETICALLY MODIFIED; COLITIS; DISEASE MODELS, ANIMAL; GROWTH SUBSTANCES; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-7; MICE; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; TUMOR NECROSIS FACTOR; ANIMALS; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035990093     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200060     Document Type: Review

References (58)

1. Inflammatory bowel disease. I
2. Animal models of intestinal inflammation: New insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease
3. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
4. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
5. Interleukin-10-deficient mice develop chronic enterocolitis
6. Distinct inflammatory mechanisms mediate early versus late colitis in mice
7. Enhanced Thl activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
8. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
9. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease
10. A CD4+T cell population mediates development of inflammatory bowel disease in T-cell receptor alpha-deficient mice
11. The development of CD4+ T effector cells during type 2 immune response
12. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
13. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
14. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis
15. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
16. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes
17. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7
18. STATs: Signal transducers and activators of transcription
19. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
20. Chronic intestinal inflammation in STAT-4 transgenic mice: Characterization of disease and adoptive transfer by TNF-plus IFN-gamma-producing CD4+ T cells that respond to bacteria] antigens
21. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders
22. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats
23. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats
24. Varying cecal bacterial loads influence colitis and gastritis in HLA-B27 transgenic rats
25. CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
26. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
27. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain
28. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/YIT adoptive transfer model of Croh's disease in mice
29. Antibodies to interleukin 12 abrogate established experimental colitis in mice
30. Hapten-induced model of murine inflammatory bowel disease - Mucosal immune responses and protection by tolerance
31. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
32. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses
33. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice
34. Protection of trinitrobenzene suffonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice
35. A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune colitis
36. Oxazolone colitis. A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4
37. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
38. Effect of ingestion of eicosapentaenoic acid ethyl ester on carageenan-induced colitis in guinea pigs
39. Rapid production of ulcerative disease of the colon in newly weaned guinea-pigs by degraded carrageenan
40. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs
41. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury
42. Tissue interleukin I and interleukin- I receptor antagonist expression in enterocolifis in resistant and susceptible rats
43. Interleukin 10 suppresses experimental chronic granulomatous inflammation induced by bacterial cell wall polymers
44. +T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice
45. Pure E epitopes on CD45R[T200] molecules define differentiation antigens on murine B and T lymphocytes
46. +T cells
47. A monoclonal antibody to murine CD45R distinguishes CD4T cell population that produces different cytokines
48. +T cells are important for the balance between protective and pathogenic cell-mediated immunity
49. +T cells: A population of T cell with immune regulatory activities in vitro
50. +T cell subset inhibits antigen-specific T-cell responses and prevents colitis
51. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
52. +T cells
53. +T cells
54. +T cells from IFNE y knockout mice do not induce wasting disease
55. Colitis-inducing potency of CD4 1T cells in immunodeficient, adoptive hosts depends on their state of activation, IL -12 responsiveness, and CD45RB surface phenotype
56. Altered immune responses in interleukin 10 transgenic mice
57. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
58. Autoimmune intestinal pathology induced by hsp6O-specific CD8 T cells